Evaluation of HTLV-۱ activity in HAM/TSP patients using proviral load and Tax mRNA expression after In Vitro lymphocyte activation

سال انتشار: 1393
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 240

فایل این مقاله در 6 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-17-7_010

تاریخ نمایه سازی: 4 آبان 1400

چکیده مقاله:

Objective(s):HTLV-۱ is the first human retrovirus that has been recognized and is associated with HAM/TSP and ATLL. Studies have shown that less than five percent of HTLV-۱ infected carriers develop HAM/TSP or ATLL and about ninety-five percent remain asymptomatic. Therefore, the proviral load with Tax may affect cellular genes such as cytokines and oncogenes, as well as involve in pathogenicity. Materials and Methods:Thirty HAM/TSP patients, thirty HTLV-۱ healthy carriers, and MT-۲ cell line were evaluated for HTLV-۱ activity. PBMCs were isolated and activated using PMA and ionomycine. Real-time PCR and TaqMan methods were performed using specific primers and fluorescence probes for Tax expression and proviral load assessment. Β۲microglobulin (β۲m) and albumin were used as controls in Tax expression and in proviral load, respectively. Results: An insignificant increase in Tax expression was observed in rest PBMCs of HAM/TSP patients compared to healthy carriers. However, after lymphocyte activation there was a significant increase in Tax expression in HAM/TSP patients (P=۰.۰۴۲). The Proviral load in patients was significantly higher than in carriers. Moreover, there was a significant correlation between Tax mRNA expression in activated PBMCs and proviral load (R=۰.۳۷, P=۰.۰۱۲). Conclusion: Although proviral load had been addressed as a valuable index for monitoring HTLV-۱ infected subjects, the results of this study demonstrated that Tax expression in activated PBMCs along with proviral load assessment in HAM/TSP patients are a more reliable factor for determining the prognosis and monitoring healthy carriers and HAM/TSP patients.

کلیدواژه ها:

نویسندگان

Atefeh Yari

Microbiology and Virology Research Center, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran Virology Department, Public Health School, Tehran University of Medical Sciences, Tehran, Iran

Seyyed Abdolrahim Rezaee

Immunology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Narges Valizadeh

Inflammation and Inflammatory diseases Research Center, Faculty of Medicine, Mashhad University of Medical Science, Mashhad, Iran

Taraneh Rajaee

Inflammation and Inflammatory diseases Research Center, Faculty of Medicine, Mashhad University of Medical Science, Mashhad, Iran

Seyyed Mohammad Jazayeri

Virology Department, Public Health School, Tehran University of Medical Sciences, Tehran, Iran

Mojdeh Soltani

Virology Department, Public Health School, Tehran University of Medical Sciences, Tehran, Iran

Mehdi Norouzi

Virology Department, Public Health School, Tehran University of Medical Sciences, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Rezaee SA, Fazly Bazzaz BS. The significance of HTLV-I in ...
  • Rafatpanah H, Rezaee A, Etemadi M, Farid Hossseini R, Khorram ...
  • Franchini G. Molecular mechanisms of humanT-cell leukemia/ lymphotropic virus type ...
  • Vakili R, Sabet F, Ahmadi Ghezeldasht S, Boostani R, Rafatpanah ...
  • Yakova M, Lezin A, Dantin F, Lagathu G, Olindo S, ...
  • Manns A, Hisada M, LaGrenade L. HumanT-lymphotropicvirus type I infection. ...
  • Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F, Bidkhori HR, Shamsian SK, ...
  • Yamano Y, Nagai M, Brennan M, Mora CA, Soldan SS, ...
  • Mortreux F, Gabet AS, Wattel E. Molecular and cellular aspects ...
  • Jacobson S, Zaninovic V, Mora C, Rodgers-Johnson P, Sheremata WA, ...
  • Jacobson S, Gupta A, Mattson D, Mingioli E, Mc-Farlin DE. ...
  • Nyborg JK, Dynan WS. Interaction of cellular proteins with the ...
  • Masuda ES, Imamura R, Amasaki Y, Arai,and K, Arai N. ...
  • Hatanaka M, Kobayashi N. The pX region of HTLV-I. Princess ...
  • Bindhu M, Nair A, Lairmore MD. Role of accessory proteins ...
  • Pique C, Dokhelar MC. In vivo production of proteins of ...
  • Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, ...
  • Manns A, Miley WJ, Wilks RJ, Morgan OS, Hanchard B, ...
  • Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, ...
  • Iwanaga M, Watanabe T, Utsunomiya T, Okayama M, Uchimaru K, ...
  • Goncalves DU, Proietti FA, Barbosa Stancioli EF, Martins ML, Ribas ...
  • Rios Grassi MF, Olavarria VN, Kruschewsky RdA, Mascarenhas RE, Dourado ...
  • Matsuura E, Yamano Y, Jacobson S. Neuroimmunity of HTLV-I Infection. ...
  • Miyoshi I, Kubonishi I,Yoshimoto S, Akagi T, Ohtsuki Y, Shiraishi ...
  • Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, ...
  • Dheda K, Huggett JF, Bustin SA, Johnson MA, Rook G, ...
  • Dehee A, Cesaire R, Desire N, Lezin A, Bourdonne O, ...
  • Kalavi Kh, Moradi A, Tabarraei A. Population based sero prevalence ...
  • Lin HC, Dezzutti CS, Lal RB, Rabson AB. Activation of ...
  • Lin HC, Hickey M, Hsu L, Medina D, Rabson AB. ...
  • Lin HC, Charlene S, Dezzutti, Renu B. Lal,A, Rabson AB. ...
  • Furukawa Y, Saito M, Matsumoto W, Usuku K, Tanaka Y, ...
  • Best I, Adaui V, Verdonck K, González E, Tipismana M, ...
  • Barmak K, Harhaj E, Grant C, Alefantis T, Wigdahl B. ...
  • Bangham CR, Hall SE, Jeffery KJ, Vine AM, Witkover A, ...
  • Akagi T, Ono H, Nyunoya H, Shimotohno K. Characterization of ...
  • Grassmann R, Dengler C, Muller-Fleckenstein I, Fleckenstein B, McGuire K, ...
  • نمایش کامل مراجع